MedTrace Logo

Spectral CT Clinical Trial Protocol

NCT05017233 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2024-05-17

No results posted yet for this study

Summary

The purpose of this study was to evaluate the expected effectiveness, ease of operation, stability, and safety of Spectral CT

Conditions

  • CT Scanning

Interventions

DEVICE

Spectral CT

Using Spectral CT to scan Breast

Sponsors & Collaborators

  • Shanghai Changzheng Hospital

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Philips (China) Investment CO., LTD

    lead INDUSTRY

Principal Investigators

  • Shiyuan Liu, Director · Shanghai Changzheng Hospital

  • Fuhua Yan, Director · Ruijin Hospital

  • Bin Song, Director · West China Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-04
Primary Completion
2022-11-01
Completion
2023-02-12
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05017233 on ClinicalTrials.gov